BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 23775960)

  • 1. African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?
    Sundi D; Ross AE; Humphreys EB; Han M; Partin AW; Carter HB; Schaeffer EM
    J Clin Oncol; 2013 Aug; 31(24):2991-7. PubMed ID: 23775960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary on "African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?" Sundi D, Ross AE, Humphreys EB, Han M, Partin AW, Carter HB, Schaeffer EM, Johns Hopkins University, Baltimore, MD. J Clin Oncol 2013; 31(24):2991-7. [Epub 2013 Jun 17]. doi: 10.1200/JCO.2012.47.0302.
    Eggener S
    Urol Oncol; 2014 Aug; 32(6):936. PubMed ID: 25087674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up.
    Faisal FA; Sundi D; Cooper JL; Humphreys EB; Partin AW; Han M; Ross AE; Schaeffer EM
    Urology; 2014 Dec; 84(6):1434-41. PubMed ID: 25432835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men.
    Yamoah K; Deville C; Vapiwala N; Spangler E; Zeigler-Johnson CM; Malkowicz B; Lee DI; Kattan M; Dicker AP; Rebbeck TR
    Urol Oncol; 2015 Feb; 33(2):70.e15-22. PubMed ID: 25304288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
    Jalloh M; Myers F; Cowan JE; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Mar; 67(3):451-7. PubMed ID: 24746973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Low Socioeconomic Status With Adverse Prostate Cancer Pathology Among African American Men Who Underwent Radical Prostatectomy.
    Weprin SA; Parker DC; Jones JD; Kaplan JR; Giusto LL; Mydlo JH; Yu SS; Lee DI; Eun DD; Reese AC
    Clin Genitourin Cancer; 2019 Oct; 17(5):e1054-e1059. PubMed ID: 31303559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. African-american race is a predictor of seminal vesicle invasion after radical prostatectomy.
    Yamoah K; Walker A; Spangler E; Zeigler-Johnson CM; Malkowicz B; Lee DI; Dicker AP; Rebbeck TR; Lal P
    Clin Genitourin Cancer; 2015 Apr; 13(2):e65-72. PubMed ID: 25450037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature review.
    Gökce MI; Sundi D; Schaeffer E; Pettaway C
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):127-136. PubMed ID: 28417980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy.
    Faisal FA; Kaur HB; Tosoian JJ; Tomlins SA; Schaeffer EM; Lotan TL
    Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):552-559. PubMed ID: 30850708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Population-Based Study of Men With Low-Volume Low-Risk Prostate Cancer: Does African-American Race Predict for More Aggressive Disease?
    Schreiber D; Chhabra A; Rineer J; Weedon J; Schwartz D
    Clin Genitourin Cancer; 2015 Aug; 13(4):e259-e264. PubMed ID: 25777681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy.
    Jeong IG; Dajani D; Verghese M; Hwang J; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY
    Urol Oncol; 2016 Jan; 34(1):3.e9-14. PubMed ID: 26345648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance.
    Ha YS; Salmasi A; Karellas M; Singer EA; Kim JH; Han M; Partin AW; Kim WJ; Lee DH; Kim IY
    Urology; 2013 Apr; 81(4):831-5. PubMed ID: 23465143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men.
    Sundi D; Kryvenko ON; Carter HB; Ross AE; Epstein JI; Schaeffer EM
    J Urol; 2014 Jan; 191(1):60-7. PubMed ID: 23770146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 17-Gene Panel Genomic Prostate Score Has Similar Predictive Accuracy for Adverse Pathology at Radical Prostatectomy in African American and European American Men.
    Murphy AB; Carbunaru S; Nettey OS; Gornbein C; Dixon MA; Macias V; Sharifi R; Kittles RA; Yang X; Kajdacsy-Balla A; Gann P
    Urology; 2020 Aug; 142():166-173. PubMed ID: 32277993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance.
    Deka R; Parsons JK; Simpson DR; Riviere P; Nalawade V; Vitzthum LK; Kader AK; Kane CJ; Rock CS; Murphy JD; Rose BS
    Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):581-588. PubMed ID: 32327702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy.
    Tosoian JJ; Almutairi F; Morais CL; Glavaris S; Hicks J; Sundi D; Humphreys E; Han M; De Marzo AM; Ross AE; Tomlins SA; Schaeffer EM; Trock BJ; Lotan TL
    Eur Urol; 2017 May; 71(5):697-700. PubMed ID: 27477529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Pathological Upgrading and Up Staging among Men with Low Risk Prostate Cancer Varies by Race: Results from the National Cancer Database.
    Maurice MJ; Sundi D; Schaeffer EM; Abouassaly R
    J Urol; 2017 Mar; 197(3 Pt 1):627-631. PubMed ID: 27582435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.
    Leapman MS; Freedland SJ; Aronson WJ; Kane CJ; Terris MK; Walker K; Amling CL; Carroll PR; Cooperberg MR
    J Urol; 2016 Nov; 196(5):1408-1414. PubMed ID: 27352635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.